MDxHealth SA MDXH-BE:Euronext Brussels

*Data is delayed | EUR
Last | 07/23/21 CEST
1.37quote price arrow up+0.01 (+0.37%)
Volume
12,935
52 week range
0.69 - 1.47

...

Loading . . .
  • Open1.36
  • Day High1.38
  • Day Low1.36
  • Prev Close1.37
  • 52 Week High1.47
  • 52 Week High Date05/31/21
  • 52 Week Low0.69
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap146.17M
  • Shares Out90.69M
  • 10 Day Average Volume35,292.82
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change53.93

KEY STATS

  • Open1.36
  • Day High1.38
  • Day Low1.36
  • Prev Close1.37
  • 52 Week High1.47
  • 52 Week High Date05/31/21
  • 52 Week Low0.69
  • 52 Week Low Date10/30/20
  • Market Cap146.17M
  • Shares Out90.69M
  • 10 Day Average Volume35,292.82
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change53.93

RATIOS/PROFITABILITY

  • EPS (TTM)-0.28
  • P/E (TTM)-4.84
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MDxHealth SA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
MDxHealth SA is a Belgium-based multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate...
Mark Shaffar
Non-Executive Chairman
Michael McGarrity
Chief Executive Officer
Ron Kalfus
Chief Financial Officer
Joseph Sollee
Executive Vice President
Christopher Thibodeau
Executive Vice President
Address
CAP Business Center, Rue d'Abhooz 31
Herstal
4040
Belgium